Indoco Remedies Ltd (BOM:532612)
₹ 376.45 8.55 (2.32%) Market Cap: 34.69 Bil Enterprise Value: 41.15 Bil PE Ratio: 44.57 PB Ratio: 3.06 GF Score: 79/100

Q4 2021 Indoco Remedies Ltd Earnings Call Transcript

May 25, 2021 / 10:00AM GMT
Release Date Price: ₹338.55 (-5.55%)
Operator

Ladies and gentlemen, good day, and welcome to the Indoco Remedies Q4 FY '21 Earnings Conference Call, hosted by Centrum Broking Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Ms. Cyndrella Thomas from Centrum Broking. Thank you, and over to you, ma'am.

Cyndrella Thomas Carvalho;Sundeep V. Bambolkar
Indoco Remedies Limited - Joint MD & Executive Director

Thanks, Steve. Good afternoon, everyone. Thanks for joining this Indoco Remedies Q4 Earnings Call. I hope and wish that all of you are well and safe amid this pandemic times. At the outset, I thank the management of Indoco Remedies for giving us this opportunity to host the call.

Today, from the management team, we have with us, Managing Director, Ms. Aditi Panandikar; joint Managing Director, Mr. Sundeep Bambolkar; Chief Financial Officer; Mr. Mandar Borkar; Corporate Affairs and M&A, Mr. Vilas Nagare.

With this, I hand over the call to management for the opening remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot